Pneumatic Compression Devices (PCDs / IPC / APCD)

Coverage Summary

Overview: This policy addresses pneumatic compression devices (PCDs) including traditional single- and multi-chamber pneumatic compression systems and more complex advanced pneumatic compression devices (APCDs) used for therapy such as sequential inflation/deflation to reduce venous stasis, treat edema, or augment wound healing. It defines scope for UnitedHealthcare Commercial and Individual Exchange plans and notes that member-specific benefit documents and applicable laws govern coverage decisions.

Scope and applicability: Coverage positions are mixed: APCDs for head/face/neck lymphedema and high-pressure rapid inflation/deflation devices for peripheral arterial disease (PAD) are considered unproven and not medically necessary, while pneumatic compression devices (including intermittent pneumatic compression devices) may be proven and medically necessary for certain indications (e.g., lymphedema, chronic venous insufficiency with edema and non-healing lower-extremity ulcers, and DVT prevention) when the patient meets the specific clinical criteria in the InterQual® CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices. InterQual criteria are required to determine medical necessity and prior authorization applicability.

Policy number2026T0563W

Effective dateJanuary 1, 2026

Primary coverage stances count3

Medical-Necessity Criteria

Coverage Rationale / Medical Necessity

Coverage positions summarized from policy:

ALL of the following

Advanced intermittent pneumatic compression devices (APCDs) for treating lymphedema of the head, face, or neck are considered unproven and not medically necessary.
Pneumatic compression devices (high pressure, rapid inflation/deflation cycle) for treating peripheral arterial disease (PAD) are considered unproven and not medically necessary.
Covered when specific criteria met per InterQual
- Pneumatic compression devices are proven and medically necessary in certain circumstances for the treatment of lymphedema or chronic venous insufficiency (CVI) with edema and non-healing lower extremity ulcers when medical necessity clinical coverage criteria in the InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices are met.

Coding

Referenced HCPCS / Procedure CodesHCPCS

A4600	Sleeve for intermittent limb compression device, replacement only, each
E0650	Pneumatic compressor, nonsegmental home model
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure
E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg

1–10 of 19

1/2

Provider Actions / Prior Authorization

Prior Authorization

InterQual criteria required for medical necessity

Coverage for PCDs and IPC devices is contingent on meeting the InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices medical necessity criteria; refer to InterQual for specific clinical criteria.

InterQual CP: Durable Medical Equipment, Pneumatic and other Powered Compression Devices

Documentation Required

Medical records to support coverage

Medical records documentation may be required to assess whether the member meets the clinical criteria for coverage; benefit coverage is determined by the member-specific benefit plan and applicable laws.

Background and Evidence

Device types and mechanisms: Pneumatic compression devices (PCDs) range from traditional single- or multi-chamber garments to advanced APCDs with expanded garment options and programmability; intermittent pneumatic compression (IPC) devices use inflatable sleeves that sequentially inflate and deflate (sometimes distal-to-proximal) to reduce venous stasis and stimulate fibrinolytic factors.

Indications overview: Clinical uses discussed include treatment of head/neck lymphedema (APCDs such as Flexitouch; evidence limited and APCDs for head/neck considered unproven), treatment of peripheral arterial disease/critical limb ischemia with high-pressure or high-pressure intermittent limb compression (HPIPC/HPILC) devices (evidence inconsistent; high-pressure devices for PAD considered unproven), management of chronic venous insufficiency (CVI) with edema and adjunctive treatment of hard-to-heal venous ulcers (studies show IPC plus compression may shorten time to closure), and prevention of deep venous thrombosis (DVT) in select immobilized or surgical patients (IPC shown to reduce DVT risk in some settings such as post-stroke and certain postoperative immobilization scenarios).

Study/Source	Key finding
Ridner et al. (2021) RCT for head/neck APCD	Improvement in clinician-rated external lymphedema and reduced symptoms; feasibility and safety demonstrated but no improvement in endoscopic internal lymphedema; small pilot trial needing larger RCTs
Hayes (2021/2023) Flexitouch review	Minimal support; limited studies, short follow-up, non-validated measures and no specific guidelines for device — evidence base deemed limited
Mayrovitz/Gutierrez (2020) observational / feasibility studies	Feasibility studies (n up to 205) report symptom and function improvements and high satisfaction but lack control groups so cannot establish efficacy
Alvarez et al. (2020) venous ulcers RCT	IPC + standard compression reduced median time to wound closure vs compression alone (141 vs 211 days; p=0.031) and increased healing rate and reduced pain early in follow-up
CLOTS 3 trial	IPC reduced DVT risk in immobile post-stroke patients (absolute reduction 3.6%; adjusted OR 0.65) and improved 6-month survival (HR 0.86)
Domeij-Arverud et al. (Achilles tendon RCT)	IPC for 6 hrs/day for 2 weeks reduced DVT at 2 weeks (21% vs 37%; p=0.042) but benefit not sustained at 6 weeks after IPC stopped
Cochrane (Kakkos et al., 2022)	Combined IPC + pharmacologic prophylaxis reduced PE and DVT versus pharmacologic alone (PE OR 0.46; low- to high-certainty depending on outcome)
ECRI (2021) PAD assessment	IPC may improve walking distance, rest pain and wound healing in CLI but studies at high risk of bias; consider when revascularization not possible
Oresanya et al. (2018) systematic review/meta-analysis (HPILC)	Eight RCTs showed increased walking distance (mean difference ~125 m) suggesting benefit for intermittent limb compression in claudication, but studies small and heterogeneous
Alvarez et al. (2015) HPIPC RCT for PAD/CLI	HPIPC (2 hrs/day for 16 weeks) improved peak walking time, wound surface area, pain relief and physical function versus exercise in a small RCT

Definitions / glossary: APCD (advanced pneumatic compression device) — programmable, complex garment options designed for applications including head/neck lymphedema; IPC / IPCD (intermittent pneumatic compression / device) — inflatable sleeves that sequentially inflate and deflate to reduce venous stasis and prevent DVT; HPIPC / HPILC (high-pressure intermittent limb compression / high-pressure intermittent limb compression) — higher-pressure devices evaluated for PAD/CLI (often rapid inflation/deflation cycles).

Revision History

01/01/2026template_updateLatest

01/01/2026 Summary of Changes = Template Update; no clinical policy statement changes indicated in this update.